“…At least a dozen agents with varying mechanisms have been evaluated, such as memantine, nimodipine, and selegiline. Excellent reviews of these studies have been published (e.g., [1,32]). At this time, no specific treatment is supported by large, high-quality, multicenter, randomized clinical trials.…”